Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hu Liang

Showing results (191-200 of 215) with videos related to

Pageof 22
Sort By:
Cancer Research|March 14, 2019
Genome-Wide RNAi Screen Identifies PMPCB as a Therapeutic Vulnerability in EpCAM<sup>+</sup> Hepatocellular CarcinomaAtsushi Takai, Hien Dang, Naoki Oishi, et al.
JAMA Oncology|February 17, 2022
Effect of Capecitabine Maintenance Therapy Plus Best Supportive Care vs Best Supportive Care Alone on Progression-Free Survival Among Patients With Newly Diagnosed Metastatic Nasopharyngeal Carcinoma Who Had Received Induction Chemotherapy: A Phase 3 Randomized Clinical TrialGuo-Ying Liu, Wang-Zhong Li, De-Shen Wang, et al.
International Journal of Surgery (London, England)|August 14, 2023
Development and validation of a mutation-annotated prognostic score for intrahepatic cholangiocarcinoma after resection: a retrospective cohort studyXiang-Yu Wang, Wen-Wei Zhu, Lu Lu, et al.
Hepatology (Baltimore, Md.)|June 19, 2012
Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinomaNaoki Oishi, Mia R Kumar, Stephanie Roessler, et al.
Cancer Communications (London, England)|March 31, 2019
The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective studySai-Lan Liu, Xue-Song Sun, Xiao-Yun Li, et al.
Nature Communications|February 3, 2024
Camrelizumab and apatinib plus induction chemotherapy and concurrent chemoradiotherapy in stage N3 nasopharyngeal carcinoma: a phase 2 clinical trialHu Liang, Yao-Fei Jiang, Guo-Ying Liu, et al.
Cell Metabolism|January 22, 2019
ACOT12-Dependent Alteration of Acetyl-CoA Drives Hepatocellular Carcinoma Metastasis by Epigenetic Induction of Epithelial-Mesenchymal TransitionMing Lu, Wen-Wei Zhu, Xuan Wang, et al.
Theranostics|January 6, 2022
Driver mutations of intrahepatic cholangiocarcinoma shape clinically relevant genomic clusters with distinct molecular features and therapeutic vulnerabilitiesXiang-Yu Wang, Wen-Wei Zhu, Zheng Wang, et al.
Eclinicalmedicine|August 18, 2023
Efficacy and safety of sintilimab plus bevacizumab in metastatic nasopharyngeal carcinoma after failure of platinum-based chemotherapy: an open-label phase 2 studyNian Lu, Yao-Fei Jiang, Wei-Xiong Xia, et al.
Gut|March 24, 2019
Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockadeYing Zhu, Jing Yang, Da Xu, et al.
Pageof 22

Showing results (191-200 of 215) with videos related to

Sort By:
Pageof 22
Cancer Research|March 14, 2019
Genome-Wide RNAi Screen Identifies PMPCB as a Therapeutic Vulnerability in EpCAM<sup>+</sup> Hepatocellular CarcinomaAtsushi Takai, Hien Dang, Naoki Oishi, et al.
JAMA Oncology|February 17, 2022
Effect of Capecitabine Maintenance Therapy Plus Best Supportive Care vs Best Supportive Care Alone on Progression-Free Survival Among Patients With Newly Diagnosed Metastatic Nasopharyngeal Carcinoma Who Had Received Induction Chemotherapy: A Phase 3 Randomized Clinical TrialGuo-Ying Liu, Wang-Zhong Li, De-Shen Wang, et al.
International Journal of Surgery (London, England)|August 14, 2023
Development and validation of a mutation-annotated prognostic score for intrahepatic cholangiocarcinoma after resection: a retrospective cohort studyXiang-Yu Wang, Wen-Wei Zhu, Lu Lu, et al.
Hepatology (Baltimore, Md.)|June 19, 2012
Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinomaNaoki Oishi, Mia R Kumar, Stephanie Roessler, et al.
Cancer Communications (London, England)|March 31, 2019
The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective studySai-Lan Liu, Xue-Song Sun, Xiao-Yun Li, et al.
Nature Communications|February 3, 2024
Camrelizumab and apatinib plus induction chemotherapy and concurrent chemoradiotherapy in stage N3 nasopharyngeal carcinoma: a phase 2 clinical trialHu Liang, Yao-Fei Jiang, Guo-Ying Liu, et al.
Cell Metabolism|January 22, 2019
ACOT12-Dependent Alteration of Acetyl-CoA Drives Hepatocellular Carcinoma Metastasis by Epigenetic Induction of Epithelial-Mesenchymal TransitionMing Lu, Wen-Wei Zhu, Xuan Wang, et al.
Theranostics|January 6, 2022
Driver mutations of intrahepatic cholangiocarcinoma shape clinically relevant genomic clusters with distinct molecular features and therapeutic vulnerabilitiesXiang-Yu Wang, Wen-Wei Zhu, Zheng Wang, et al.
Eclinicalmedicine|August 18, 2023
Efficacy and safety of sintilimab plus bevacizumab in metastatic nasopharyngeal carcinoma after failure of platinum-based chemotherapy: an open-label phase 2 studyNian Lu, Yao-Fei Jiang, Wei-Xiong Xia, et al.
Gut|March 24, 2019
Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockadeYing Zhu, Jing Yang, Da Xu, et al.
Pageof 22